Insulet Corporation

NasdaqGS:PODD Stock Report

Market Cap: US$11.8b

Insulet Management

Management criteria checks 3/4

Insulet's CEO is Jim Hollingshead, appointed in Jun 2022, has a tenure of 1.75 years. total yearly compensation is $11.18M, comprised of 3.9% salary and 96.1% bonuses, including company stock and options. directly owns 0.02% of the company’s shares, worth $2.41M. The average tenure of the management team and the board of directors is 3.8 years and 5.2 years respectively.

Key information

Jim Hollingshead

Chief executive officer

US$11.2m

Total compensation

CEO salary percentage3.9%
CEO tenure1.8yrs
CEO ownership0.02%
Management average tenure3.8yrs
Board average tenure5.2yrs

Recent management updates

Recent updates

Insulet (NASDAQ:PODD) Is Doing The Right Things To Multiply Its Share Price

Feb 19
Insulet (NASDAQ:PODD) Is Doing The Right Things To Multiply Its Share Price

Is Insulet Corporation (NASDAQ:PODD) Potentially Undervalued?

Jan 22
Is Insulet Corporation (NASDAQ:PODD) Potentially Undervalued?

Insulet: An Interesting, Yet Expensive, Story

Jan 10

Is Insulet (NASDAQ:PODD) Using Too Much Debt?

Jan 09
Is Insulet (NASDAQ:PODD) Using Too Much Debt?

Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors

Dec 27
Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors

Estimating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)

Nov 14
Estimating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)

Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To Continue

Oct 31
Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To Continue

We Think Insulet (NASDAQ:PODD) Is Taking Some Risk With Its Debt

Oct 01
We Think Insulet (NASDAQ:PODD) Is Taking Some Risk With Its Debt

Is There Now An Opportunity In Insulet Corporation (NASDAQ:PODD)?

Sep 16
Is There Now An Opportunity In Insulet Corporation (NASDAQ:PODD)?

Estimating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)

Aug 14
Estimating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)

Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger

Jul 31
Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger

Is Insulet (NASDAQ:PODD) Using Too Much Debt?

Jun 18
Is Insulet (NASDAQ:PODD) Using Too Much Debt?

Getting In Cheap On Insulet Corporation (NASDAQ:PODD) Might Be Difficult

May 22
Getting In Cheap On Insulet Corporation (NASDAQ:PODD) Might Be Difficult

Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger

Apr 30
Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger

Here's Why Insulet (NASDAQ:PODD) Has A Meaningful Debt Burden

Jan 24
Here's Why Insulet (NASDAQ:PODD) Has A Meaningful Debt Burden

Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To Continue

Dec 28
Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To Continue

Insulet: An Overpriced Play In The Medical Space

Oct 18

Insulet (NASDAQ:PODD) Has A Pretty Healthy Balance Sheet

Oct 02
Insulet (NASDAQ:PODD) Has A Pretty Healthy Balance Sheet

Insulet automated insulin delivery system Omnipod 5 gets CE mark

Sep 20

The Return Trends At Insulet (NASDAQ:PODD) Look Promising

Sep 05
The Return Trends At Insulet (NASDAQ:PODD) Look Promising

Insulet wins FDA nod to use insulin delivery system in 2 – 5-year-olds

Aug 22

Insulet: Bullish Factors For Portfolio Inclusion

Jul 23

Insulet to pay $20M to Roche in patent settlement

Jul 11

Returns On Capital Are Showing Encouraging Signs At Insulet (NASDAQ:PODD)

Jun 06
Returns On Capital Are Showing Encouraging Signs At Insulet (NASDAQ:PODD)

Is Insulet (NASDAQ:PODD) Using Too Much Debt?

May 16
Is Insulet (NASDAQ:PODD) Using Too Much Debt?

CEO Compensation Analysis

How has Jim Hollingshead's remuneration changed compared to Insulet's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

US$206m

Sep 30 2023n/an/a

US$120m

Jun 30 2023n/an/a

US$63m

Mar 31 2023n/an/a

US$600k

Dec 31 2022US$11mUS$440k

US$5m

Sep 30 2022n/an/a

US$17m

Jun 30 2022n/an/a

US$35m

Mar 31 2022n/an/a

US$45m

Dec 31 2021US$290kn/a

US$17m

Sep 30 2021n/an/a

-US$29m

Jun 30 2021n/an/a

-US$30m

Mar 31 2021n/an/a

US$9m

Dec 31 2020US$259kn/a

US$7m

Sep 30 2020n/an/a

US$29m

Jun 30 2020n/an/a

US$18m

Mar 31 2020n/an/a

US$5m

Dec 31 2019US$261kn/a

US$12m

Compensation vs Market: Jim's total compensation ($USD11.18M) is about average for companies of similar size in the US market ($USD12.45M).

Compensation vs Earnings: Jim's compensation has increased by more than 20% in the past year.


CEO

Jim Hollingshead (60 yo)

1.8yrs

Tenure

US$11,176,917

Compensation

Dr. James R. Hollingshead, also known as Jim, Ph.D. had been President of Sleep & Respiratory Care Business at ResMed Inc. since July 2020 until May 05, 2022 and served as its President of Sleep Business s...


Leadership Team

NamePositionTenureCompensationOwnership
James Hollingshead
President1.8yrsUS$11.18m0.020%
$ 2.4m
Shacey Petrovic
Director & Advisor1.8yrsUS$16.97m0.045%
$ 5.4m
Eric Benjamin
Executive VP6.1yrsUS$2.55m0.024%
$ 2.9m
Lauren Budden
Group VP4.9yrsno data0.0082%
$ 965.3k
Prem Singh
Senior Vice President of Global Operations1.2yrsno data0.0077%
$ 913.3k
Mark Field
Senior VP & CTOless than a yearno data0.023%
$ 2.8m
Deborah Gordon
Vice President of Investor Relations9.2yrsno datano data
John Kapples
Senior VP & General Counsel5yrsUS$2.03m0.021%
$ 2.5m
Laetitia Cousin
Senior VP of Regulatory Affairs1.3yrsno data0.0044%
$ 526.4k
Angela Wiczek
Senior Director of Corporate Communicationsno datano datano data
Philip Hildale
Senior Vice President of Sales & Customer Care9.2yrsno datano data
Dan Manea
Senior VP & Chief Human Resources Officer3.8yrsUS$1.74m0.0062%
$ 735.8k

3.8yrs

Average Tenure

51yo

Average Age

Experienced Management: PODD's management team is considered experienced (3.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
James Hollingshead
President4.7yrsUS$11.18m0.020%
$ 2.4m
Shacey Petrovic
Director & Advisor5.5yrsUS$16.97m0.045%
$ 5.4m
Elizabeth Weatherman
Independent Director2.1yrsUS$561.51k0.0023%
$ 274.5k
Timothy Scannell
Independent Chairman9.6yrsUS$344.09k0.036%
$ 4.3m
Robert Sherwin
Chairman of Scientific Advisory Boardno datano datano data
Howard Wolpert
Member of Scientific Advisory Boardno datano datano data
Margaret Lawlor
Member of Educator Advisory Boardno datano datano data
Camille Izlar
Member of Educator Advisory Boardno datano datano data
Mary Halvorson
Member of Educator Advisory Boardno datano datano data
Steven Edelman
Member of Scientific Advisory Boardno datano datano data
Anne Daly
Member of Educator Advisory Boardno datano datano data
Corinne Nevinny
Independent Director5.2yrsUS$298.28k0.0074%
$ 874.2k

5.2yrs

Average Tenure

61.5yo

Average Age

Experienced Board: PODD's board of directors are considered experienced (5.2 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.